LENZ Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing aceclidine-based eye drop to enhance vision in patients diagnosed with presbyopia. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
LENZ Therapeutics Dividend Announcement
• LENZ Therapeutics announced a annually dividend of $0.15 per ordinary share which will be made payable on . Ex dividend date: 2024-03-22
• LENZ Therapeutics annual dividend for 2024 was $0.15
• LENZ Therapeutics's trailing twelve-month (TTM) dividend yield is 20.17%
LENZ Therapeutics Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2024-03-22 | $0.15 | annually |
LENZ Therapeutics Dividend per year
LENZ Therapeutics Dividend Yield
LENZ Therapeutics current trailing twelve-month (TTM) dividend yield is 20.17%. Interested in purchasing LENZ Therapeutics stock? Use our calculator to estimate your expected dividend yield:
LENZ Therapeutics Financial Ratios
P/E ratio-16.18
PEG ratio-0.16
P/B ratio4.51
ROE-30.40%
Payout ratio0.00%
Current ratio28.63
Quick ratio28.63
Cash Ratio5.32
LENZ Therapeutics Dividend FAQ
Does LENZ Therapeutics stock pay dividends?
LENZ Therapeutics does not currently pay dividends to its shareholders.
Has LENZ Therapeutics ever paid a dividend?
No, LENZ Therapeutics has no a history of paying dividends to its shareholders. LENZ Therapeutics is not known for its dividend payments.
Why doesn't LENZ Therapeutics pay dividends?
There are several potential reasons why LENZ Therapeutics would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will LENZ Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While LENZ Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is LENZ Therapeutics a dividend aristocrat?
LENZ Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is LENZ Therapeutics a dividend king?
LENZ Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is LENZ Therapeutics a dividend stock?
No, LENZ Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy LENZ Therapeutics stocks?
To buy LENZ Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy LENZ Therapeutics stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy LENZ Therapeutics stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.